Compounds > clasto-lactacystin beta-lactone
Page last updated: 2024-09-05

clasto-lactacystin beta-lactone and etoposide

clasto-lactacystin beta-lactone has been researched along with etoposide in 1 studies

Compound Research Comparison

Studies
(clasto-lactacystin beta-lactone)		Trials
(clasto-lactacystin beta-lactone)		Recent Studies (post-2010)
(clasto-lactacystin beta-lactone)		Studies
(etoposide)		Trials
(etoposide)		Recent Studies (post-2010) (etoposide)
8501518,3063,6934,900

Protein Interaction Comparison

ProteinTaxonomyclasto-lactacystin beta-lactone (IC50)etoposide (IC50)
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]Homo sapiens (human)1.153
nuclear receptor coactivator 3 isoform aHomo sapiens (human)1.4284
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)3.187
Caspase-3Homo sapiens (human)1
DNA topoisomerase 2-betaHomo sapiens (human)0.4299
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)4.18

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anwar, A; Fujita, M; Norris, DA1

Other Studies

1 other study(ies) available for clasto-lactacystin beta-lactone and etoposide

ArticleYear
Ubiquitin proteasomal pathway mediated degradation of p53 in melanoma.
    Archives of biochemistry and biophysics, 2011, Apr-15, Volume: 508, Issue:2

    Topics: Animals; Cell Line, Tumor; Etoposide; G1 Phase; Gene Deletion; Genes, p16; Half-Life; Humans; Lactones; Leupeptins; Melanocytes; Melanoma; Mice; Mice, Transgenic; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Stability; Tumor Suppressor Protein p53; Ubiquitin

2011